(Press-News.org) In recognition of her innovative experimental approaches and breakthrough discoveries on the genetic mechanisms of neurodevelopmental disorders, Dr. Xin Jin has been named the 2026 Peter Gruss Young Investigator.
“The field of nominees was incredibly impressive; however, Dr. Jin stood out among the nominees for her creative and multidisciplinary integration of methodologies to make tremendous progress toward understanding principles of brain development and function. She is well on her way to becoming a leader in the neuroscience field,” said Dr. David Fitzpatrick, Scientific Director and CEO of MPFI and a member of the PGYIA selection committee.
Unraveling the Genetic Mechanisms Behind Brain Development and Disease
Dr. Jin is an HHMI Freeman Hrabowski Scholar and an Associate Professor of Neuroscience at Scripps Research. She is also a member of the Dorris Neuroscience Center and an Adjunct Professor of Cognitive Science at UC San Diego. Her work has overcome a long-standing hurdle in understanding the genetic contributions to developmental brain diseases and disorders. By developing and optimizing new technologies, including high-throughput, multiplexed in vivo screening approaches, Dr. Jin and her team are accelerating the understanding of gene mutations in the brain. Her strategy allows for the simultaneous investigation of the diverse effects of multiple genetic mutations on cellular mechanisms across various cell types and tissues during development. Through these innovations, her lab aims to uncover the fundamental principles by which genomes build and maintain complex neural systems over time and how mutations related to various disorders impact these systems.
“The fields of neurodevelopmental and psychiatric disorders have been longing for a ‘convergence’ to map the heterogeneous genetic mutations onto a limited subset of signaling pathways on which they act. Now for the first time, Xin’s work has demonstrated the possibility of identifying such subsets in key pathways,” described Nobel laureate Dr. Ardem Patapoutian, who nominated Dr. Jin for the award.
Dr. Jin earned her B.Sc. in Chemistry from MIT and her Ph.D. in Biology from The Rockefeller University, working in the Lab of Cori Bargmann. As a Junior Fellow at the Harvard Society of Fellows, she developed and applied in vivo high-content genetic screening technologies to study brain development and homeostasis. She has received the Pew Biomedical Scholar, McKnight Scholar Award, Early Career Investigator Award from the International Society of Autism Research, and was named as one of the ‘35 Innovators Under 35’ by MIT Tech Review.
About the Peter Gruss Young Investigator Award
The Peter Gruss Young Investigator Award is awarded biennially by the Max Planck Florida Institute for Neuroscience to recognize a young neuroscience investigator who has made significant contributions through collaboration, creativity, and curiosity‑driven research. The award honors the legacy of Dr. Peter Gruss’s work as former President of the Max Planck Society and key founder of MPFI.
“I’m absolutely thrilled and deeply honored,” describes Dr. Jin. “It’s especially meaningful to be recognized in the name of Peter Gruss — a fearless leader and also a developmental biologist whose work has long inspired me.”
As the 2026 Peter Gruss Young Investigator Award recipient, Dr. Jin will receive a $5000 prize and will deliver a keynote lecture at MPFI’s Sunposium Conference on March 10, 2026 in West Palm Beach. Dr. Jin is the 4th recipient of this award; previous winners include Dr. Michael Yartsev, Dr. Gloria Choi, and Dr. Viviana Gradinaru.
This award is made possible through the generous support of Ms. Raquel Rodriguez, a lawyer and the Chair of the Florida Offices of the law firm Buchanan Ingersoll & Rooney. Ms. Rodriguez is a long-time supporter of MPFI’s work and the life science industry and supports the award in honor of Dr. Peter Gruss’s legacy as president of the Max Planck Society.
END
Dr. Xin Jin named 2026 Peter Gruss Young Investigator
2025-11-03
ELSE PRESS RELEASES FROM THIS DATE:
New antibody therapy reawakens immune system to fight pancreatic cancer
2025-11-03
Pancreatic cancer is one of the deadliest cancers, often diagnosed late and resistant to treatment
Scientists discovered a new sugar-based cloak that helps tumor cells evade the immune system
An experimental antibody blocked that disguise, reawakening immune cells and slowing tumor growth in mice
Northwestern team is now refining the antibody for human studies
CHICAGO --- Pancreatic cancer is notoriously hard to treat and often resists the most advanced immunotherapies. Northwestern Medicine scientists have uncovered a novel explanation for that resistance: Pancreatic ...
David B. Allison, PhD (Baylor College of Medicine), Lauren Hunt PhD, RN, FNP (UCSF), and Arlan Richardson, PhD (University of Oklahoma Health Sciences) to be honored with AFAR annual scientific Awards
2025-11-03
New York, NY and Boston, MA -- The American Federation for Aging Research (AFAR), a national non-profit whose mission is to support and advance healthy aging through biomedical research, will host its annual Scientific Awards of Distinction ceremony in conjunction with the Annual Scientific Meeting of the Gerontological Society of America (GSA), on November 13, 2025 from 6:30pm-9:00pm ET in Room 306 of the Hynes Convention Center in Boston, Massachusetts.
AFAR Scientific Director Steven N. Austad, PhD, will host ...
145 families receive a diagnosis with new genomic method
2025-11-03
A new genomic method has enabled multiple people with rare conditions to receive diagnoses that were previously unattainable by identifying complex structural genetic changes that are often missed by standard tests.
Researchers at the Wellcome Sanger Institute, Genomics England, Cambridge University Hospitals, and their collaborators analysed the DNA from 13,700 parents and children from the 100,000 Genomes Project. They found that many of these genetic changes, known as structural variants, directly disrupt genes involved ...
Postpartum psychosis: International experts seek to save lives of mothers, babies
2025-11-03
An international panel of leading women’s mental health experts – including UVA Health’s Jennifer Payne, MD – is calling to reclassify postpartum psychosis as its own category of mental illness to improve the care new mothers receive.
Postpartum psychosis is a severe psychiatric illness that is estimated to strike up to 2.6 out of every 1,000 women after they give birth. Symptoms can include mania, depression with psychotic features, impaired thinking, agitation and irritability. Left untreated, ...
Scientists build detailed map of the developing human brain, opening new pathways for Parkinson’s treatment
2025-11-03
SINGAPORE, 03 NOVEMBER 2025—Scientists from Duke-NUS Medical School and their collaborators have created one of the most comprehensive single cell maps of the developing human brain. The atlas captures nearly every cell type, their genetic fingerprints, and how they grow and interact. It also benchmarks best-in-class laboratory methods for producing high-quality neurons, marking a major step towards new therapies for Parkinson’s disease and other brain disorders.
Parkinson’s disease is Singapore’s second most common neurodegenerative disorder, affecting about three in every 1,000 people aged 50 and above[1]. The condition damages midbrain dopaminergic neurons—cells ...
USF study finds smarter way to train employees to thwart phishing scams
2025-11-03
Media Contact:
John Dudley
(814) 490-3290 (cell)
jjdudley@usf.edu
Click here for images and a PDF of the journal article
Key takeaways
Phishing “gotcha” tests may backfire: New USF-led research finds that on-the-spot phishing training can trigger defensiveness and limit learning — making employees less likely to absorb lessons that prevent future attacks.
Broader feedback builds stronger defenses: Training everyone after a phishing simulation — not just those who clicked — helped participants stay alert and resist scams for months.
Rethinking a cybersecurity ‘best practice’: The study challenges ...
Antimicrobial peptides can reduce salmonella in chickens
2025-11-03
Key Points:
Antimicrobial resistance is a growing global threat to public health, and finding alternatives to antibiotics can help combat increasing antimicrobial resistance (AMR).
A new study found that antimicrobial peptides can combat Salmonella infections in chickens, a major cause of foodborne disease in the U.S.
This discovery could help improve food safety and protect public health without relying on antibiotic use.
Washington, D.C.—Antimicrobial peptides can control Salmonella infections in chickens and thus have the potential to improve food safety and public health, according to a new study. The study was published in Microbiology Spectrum, a journal of the American Society ...
Short fasts do not impair thinking ability in healthy adults
2025-11-03
Skipping breakfast or practicing intermittent fasting is unlikely to cloud most adults’ thinking in the short term, according to research published by the American Psychological Association.
Fasting, which can involve abstaining from food for several hours to days, has become one of the more popular contemporary eating regimens, often promoted for potential health benefits such as improved insulin sensitivity, cellular repair and weight management.
“While fasting has become trendy over the years, there is widespread concern, often reflected in common sayings like, ‘You’re not ...
Bill Gropp named chair of CRA’s Computing Community Consortium
2025-11-03
National Center for Supercomputing Applications Director Bill Gropp was selected as the next chair of the Computing Research Association’s Computing Community Consortium (CCC). Gropp will formally begin his term following approval from the U.S. National Science Foundation, serving in the role through June 30, 2028.
Gropp joined the CCC in 2020 and has been a member of its executive committee since 2021, helping guide the group’s strategy through a challenging environment for computing research while remaining committed to the values he’s displayed ...
Novel S-Scheme photocatalyst efficiently purifies antibiotic-contaminated water
2025-11-03
A breakthrough study published in Chinese Journal of Catalysis presents a powerful new tool in the fight against water pollution: an S-scheme heterojunction photocatalyst that efficiently degrades antibiotic contaminants. This innovative material, composed of Mn0.5Cd0.5S/In2S3 (MCS/IS), not only cleans water effectively but also significantly reduces the toxicity of the breakdown products, addressing a critical challenge in environmental remediation.
The widespread use and improper disposal of antibiotics like tetracycline hydrochloride (TCH) have led to their accumulation in water sources, posing severe threats to ecosystem health and contributing to the rise of antibiotic-resistant ...